FR2232563A1 - - Google Patents

Info

Publication number
FR2232563A1
FR2232563A1 FR7419711A FR7419711A FR2232563A1 FR 2232563 A1 FR2232563 A1 FR 2232563A1 FR 7419711 A FR7419711 A FR 7419711A FR 7419711 A FR7419711 A FR 7419711A FR 2232563 A1 FR2232563 A1 FR 2232563A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7419711A
Other languages
French (fr)
Other versions
FR2232563B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2232563A1 publication Critical patent/FR2232563A1/fr
Application granted granted Critical
Publication of FR2232563B1 publication Critical patent/FR2232563B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • C08G73/0213Preparatory process
    • C08G73/0226Quaternisation of polyalkylene(poly)amines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0233Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7419711A 1973-06-11 1974-06-07 Expired FR2232563B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36904273A 1973-06-11 1973-06-11
US46226374A 1974-04-19 1974-04-19

Publications (2)

Publication Number Publication Date
FR2232563A1 true FR2232563A1 (en) 1975-01-03
FR2232563B1 FR2232563B1 (en) 1979-06-15

Family

ID=27004425

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7419711A Expired FR2232563B1 (en) 1973-06-11 1974-06-07

Country Status (20)

Country Link
JP (1) JPS5034095A (en)
AR (1) AR206115A1 (en)
AT (1) AT354096B (en)
BG (1) BG27910A3 (en)
CA (1) CA1075847A (en)
CH (1) CH614456A5 (en)
DD (1) DD111386A5 (en)
DE (1) DE2427938A1 (en)
DK (1) DK290174A (en)
ES (3) ES427097A1 (en)
FI (1) FI58787C (en)
FR (1) FR2232563B1 (en)
GB (1) GB1470538A (en)
HU (1) HU174792B (en)
IE (1) IE39795B1 (en)
IL (1) IL44957A (en)
LU (1) LU70277A1 (en)
NL (1) NL7407310A (en)
NO (1) NO741963L (en)
SE (1) SE7407017L (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996039156A2 (en) * 1995-06-06 1996-12-12 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1998036002A1 (en) * 1997-02-17 1998-08-20 Aventis Research & Technologies Gmbh & Co Kg Cross-linked vinyl polymers with bile acid adsorbing effect
US8187631B2 (en) 1999-10-19 2012-05-29 Genzyme Corporation Direct compression polymer tablet core
US9095509B2 (en) 2005-09-15 2015-08-04 Genzyme Corporation Sachet formulation for amine polymers
US9895315B2 (en) 2004-11-01 2018-02-20 Genzyme Corporation Aliphatic amine polymer salts for tableting
US11267924B2 (en) 2014-12-18 2022-03-08 Genzyme Corporation Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
JPS53109921A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
JPS53109915A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
JPS53109920A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
JPS53109922A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
JPS53109918A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
JPS53109919A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
JPS53109914A (en) * 1977-01-29 1978-09-26 Kureha Chem Ind Co Ltd Preparation of anti-tumor polysaccharides
FI67483C (en) * 1977-02-17 1985-04-10 Merck & Co Inc PROCEDURE FOR THE FRAMEWORK OF ETHCYCLE ADMINISTRATION OF PHARMACOLOGICAL PRODUCT AGAINST GALLSYRAK COMPLEX BILDANDE ADSORBATE PREPARATION
US4837005A (en) * 1986-09-30 1989-06-06 Union Carbide Corporation Partially hydrolyzed, poly(N-acyl)alkylenimines in personal care
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459151B2 (en) 1993-08-11 2008-12-02 Genzyme Corporation Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
EP1133989A3 (en) * 1993-08-11 2004-05-12 Genzyme Corporation Polymer compositions for use in therapy
US6858203B2 (en) 1993-08-11 2005-02-22 Genzyme Corporation Method of making phosphate-binding polymers for oral administration
EP0716606A1 (en) * 1993-08-11 1996-06-19 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
EP0716606A4 (en) * 1993-08-11 1999-12-22 Geltex Pharma Inc Phosphate-binding polymers for oral administration
EP1133989A2 (en) * 1993-08-11 2001-09-19 Geltex Pharmaceuticals, Inc. Polymer compositions for use in therapy
US6509013B1 (en) 1993-08-11 2003-01-21 Geltex Pharmaceuticals, Inc. Method of making phosphate-binding polymers for oral administration
US7014846B2 (en) 1993-08-11 2006-03-21 Genzyme Corporation Phosphate-binding polymers for oral administration
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996039156A3 (en) * 1995-06-06 1997-03-27 Geltex Pharma Inc Phosphate-binding polymers for oral administration
WO1996039156A2 (en) * 1995-06-06 1996-12-12 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1998036002A1 (en) * 1997-02-17 1998-08-20 Aventis Research & Technologies Gmbh & Co Kg Cross-linked vinyl polymers with bile acid adsorbing effect
US8187631B2 (en) 1999-10-19 2012-05-29 Genzyme Corporation Direct compression polymer tablet core
US9931358B2 (en) 1999-10-19 2018-04-03 Genzyme Corporation Direct compression polymer tablet core
US9895315B2 (en) 2004-11-01 2018-02-20 Genzyme Corporation Aliphatic amine polymer salts for tableting
US9095509B2 (en) 2005-09-15 2015-08-04 Genzyme Corporation Sachet formulation for amine polymers
US11267924B2 (en) 2014-12-18 2022-03-08 Genzyme Corporation Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes

Also Published As

Publication number Publication date
NL7407310A (en) 1974-12-13
HU174792B (en) 1980-03-28
FI166174A (en) 1974-12-12
JPS5034095A (en) 1975-04-02
FR2232563B1 (en) 1979-06-15
ES448117A1 (en) 1977-11-01
IL44957A0 (en) 1974-09-10
DE2427938A1 (en) 1975-01-02
IL44957A (en) 1977-05-31
AR206115A1 (en) 1976-06-30
CA1075847A (en) 1980-04-15
FI58787C (en) 1981-04-10
AU6976274A (en) 1975-12-04
FI58787B (en) 1980-12-31
IE39795B1 (en) 1979-01-03
NO741963L (en) 1975-01-06
DK290174A (en) 1975-02-03
CH614456A5 (en) 1979-11-30
AT354096B (en) 1979-12-27
BG27910A3 (en) 1980-01-15
GB1470538A (en) 1977-04-14
DD111386A5 (en) 1975-02-12
ES427097A1 (en) 1976-09-01
LU70277A1 (en) 1975-03-06
SE7407017L (en) 1974-12-12
ES448118A1 (en) 1977-11-01
IE39795L (en) 1974-12-11
ATA472974A (en) 1979-05-15

Similar Documents

Publication Publication Date Title
FR2241321B1 (en)
AU476761B2 (en)
FR2232563B1 (en)
AU476714B2 (en)
AU476696B2 (en)
AU477823B2 (en)
AU476873B1 (en)
AU477824B2 (en)
AR195948A1 (en)
AR195311A1 (en)
AR196382A1 (en)
AR193950A1 (en)
AR196123Q (en)
BR7306620D0 (en)
AR196212Q (en)
BG19287A1 (en)
CH560448A5 (en)
BG18922A1 (en)
BG26185A3 (en)
CH1499474A4 (en)
AU479562A (en)
AU479539A (en)
AU479522A (en)
AU479521A (en)
AU479504A (en)

Legal Events

Date Code Title Description
ST Notification of lapse